Cipla's shares finished the day at Rs 1447.2, showing a slight decrease of 0.04%. Cipla is currently valued at Rs 1445.85, with a daily change of -0.14%. Over the past year, the stock has delivered ...

CipAir mobile app can facilitate earlier and convenient diagnosis of asthma, enabling people with the condition to manage it more effectively and lead a healthier life Pharma major Cipla announced the ...

"By leveraging the power of next-gen technologies, we are developing solutions that are fundamentally transforming patient care and enabling better diagnostic, treatment, and management outcomes," ...

此次提出无效的是西普拉（中国） 医药有限公司，该公司是印度第二大药厂CIPLA（西普拉）的全资子公司，该公司在廉价抗艾滋和抗癌药物方面深受 ...

Drugmaker Cipla on Monday said that it has signed a perpetual license agreement with Switzerland-based Novartis Pharma AG to manufacture and market Galvus and Galvus combination brands which are used ...